Literature DB >> 15022342

Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis.

Yuan H Yang1, Eric F Morand, Stephen J Getting, Mark Paul-Clark, Dong L Liu, Simon Yona, Robert Hannon, Julia C Buckingham, Mauro Perretti, Roderick J Flower.   

Abstract

OBJECTIVE: Annexin 1 (Anx-1) is a putative mediator of the antiinflammatory actions of glucocorticoids (GCs). This study investigated the role of Anx-1 in experimental arthritis and in GC-mediated inhibition of inflammation, using antigen-induced arthritis (AIA) in Anx-1 knockout (Anx-1(-/-)) mice.
METHODS: Arthritis was induced by intraarticular injection of methylated BSA (mBSA) in mice preimmunized with mBSA. Disease was assessed after 7 days by histologic examination of the knee joints. Serum levels of anti-mBSA IgG were determined by enzyme-linked immunosorbent assay. Cytokine messenger RNA (mRNA) expression was detected by real-time polymerase chain reaction.
RESULTS: A significant exacerbation of arthritis was observed in the Anx-1(-/-) mice compared with wild-type (WT) mice. This was associated with increased mRNA expression of synovial interleukin-1 beta, tumor necrosis factor alpha, interleukin-6, and macrophage migration inhibitory factor. Dexamethasone significantly reduced the histologic severity of synovitis and bone damage in the WT mice, but exerted no inhibitory effects in the Anx-1(-/-) mice, and also significantly reduced the serum levels of anti-mBSA IgG and the numbers of peripheral blood neutrophils and lymphocytes in WT mice, but had no such effect in Anx-1(-/-) mice.
CONCLUSION: Anx-1 exerts endogenous antiinflammatory effects on AIA via the regulation of cytokine gene expression, and also mediates the antiinflammatory actions of dexamethasone in AIA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15022342     DOI: 10.1002/art.20201

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  63 in total

1.  Impaired phagocytic mechanism in annexin 1 null macrophages.

Authors:  Simon Yona; Sigrid E M Heinsbroek; Leanne Peiser; Siamon Gordon; Mauro Perretti; Roderick J Flower
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Combined Fluorescence and Magnetic Resonance Imaging of Primary Macrophage Migration to Sites of Acute Inflammation Using Near-Infrared Fluorescent Magnetic Nanoparticles.

Authors:  Sungmin Kang; Ho Won Lee; Young Hyun Jeon; Thoudam Debraj Singh; Yun Ju Choi; Ji Young Park; Jun Sung Kim; Hyunseung Lee; Kwan Soo Hong; Inkyu Lee; Shin Young Jeong; Sang-Woo Lee; Jeoung-Hee Ha; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

Review 3.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

Review 4.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

5.  Analyses of differential proteome of human synovial fibroblasts obtained from arthritis.

Authors:  Gan-Ping Bo; Li-Na Zhou; Wei-Feng He; Gao-Xing Luo; Xiong-Fei Jia; Cheng-Jun Gan; Guang-Xing Chen; Yong-Fei Fang; Peter Mose Larsen; Jun Wu
Journal:  Clin Rheumatol       Date:  2008-09-20       Impact factor: 2.980

6.  Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.

Authors:  Tiffany Doucette; Ganesh Rao; Arvind Rao; Li Shen; Kenneth Aldape; Jun Wei; Kristine Dziurzynski; Mark Gilbert; Amy B Heimberger
Journal:  Cancer Immunol Res       Date:  2013-08       Impact factor: 11.151

7.  Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.

Authors:  Jinquan Cai; Qun Chen; Yuqiong Cui; Jiawei Dong; Meng Chen; Pengfei Wu; Chuanlu Jiang
Journal:  Oncoimmunology       Date:  2018-02-13       Impact factor: 8.110

8.  Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.

Authors:  Giovanna Leoni; Ashfaqul Alam; Philipp-Alexander Neumann; J David Lambeth; Guangjie Cheng; James McCoy; Roland S Hilgarth; Kousik Kundu; Niren Murthy; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

9.  Downstream gene activation of the receptor ALX by the agonist annexin A1.

Authors:  Derek Renshaw; Trinidad Montero-Melendez; Jesmond Dalli; Ahmad Kamal; Vincenzo Brancaleone; Fulvio D'Acquisto; Giuseppe Cirino; Mauro Perretti
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

10.  Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors:  Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.